Dayanan, Albert T.
HRN: 20-72-87 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2023
CEFTRIAXONE 1G (VIAL)
11/21/2023
11/27/2023
IV
2g
OD
Pharyngitis; T/c Pharyngeal Abscess
Checking Final Appropriateness
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes